IHMedical A/S: Financial statements 2012
CVR: 28312768
Source: annual report 2012, Danish Business Authority
01/01/2012 – 31/12/2012
IHMedical A/S (CVR 28312768) has filed annual accounts for 2012. In 2012, the company reported a gross profit of DKK 2,543,857 and a net result of DKK -2,671. Equity in the 2012 report amounted to DKK 865,307. The solvency ratio was 29.6%.
- Gross Profit
- DKK 2,543,857
- Profit/Loss
- DKK -2,671
- Equity
- DKK 865,307
- Total Assets
- DKK 2,926,901
Official annual report
Keep an eye on IHMedical A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2012
As of May 21, 2012, Hans Morten Raaschou-Jensen has joined the board of directors of IHMedical A/S.
As of May 21, 2012, Søren Ziebe has left the board of directors of IHMedical A/S.
As of May 21, 2012, Bent Nordbø has left the board of directors of IHMedical A/S.
As of May 21, 2012, Tore Kvam is registered as vice chairman of IHMedical A/S.
About IHMedical A/S
IHMedical A/S was a Danish company of the type Aktieselskab based in Hørsholm, founded in 2005. The company has been dissolved on 18 June 2020. The company was registered under the industry Computerprogrammering. The company was previously named CELLCURA SOLUTIONS A/S and CELLCURA SOFTWARE SOLUTIONS A/S. The company has 1 employee (2018). In 2017, the company reported a gross profit of DKK -1,900,094 and a net result of DKK -4,145,683 compared with DKK -3,193,331 the year before. Equity in the 2017 report amounted to DKK -2,692,804.